亚太药业：拟投资5000.00万元设立全资子公司

Core Viewpoint - The company plans to invest 50 million yuan to establish a wholly-owned subsidiary, Zhejiang Yatai Lizhong Investment Holding Co., Ltd., to enhance its industrial development layout and improve overall competitiveness [1] Group 1: Investment Details - The investment will be made using the company's own funds and will not affect the normal operation of its existing main business [1] - The new subsidiary will be registered in Shaoxing City, Zhejiang Province, and the establishment is subject to approval from the relevant authorities [1] - The decision to invest falls within the chairman's authority and does not require board or shareholder approval, thus not constituting a related party transaction or major asset restructuring [1] Group 2: Strategic Implications - The establishment of the subsidiary aims to promote the company's long-term sustainable development [1] - The company will actively advance the necessary registration procedures and strengthen risk management [1]